The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index; 8 of the 43 sources its claims cite were checked for support.
Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome
Open accessAbstract
OBJECTIVE: The effect of diet on insulin resistance (IR) in polycystic ovary syndrome (PCOS) is controversial. Thus, we conducted this systematic review and meta-analysis to evaluate whether diet could reduce IR in women with PCOS while providing optimal and precise nutrition advice for clinical practice. DESIGN: The search was conducted in 8 databases through June 30, 2019. The systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. A random-effects model was adopted to calculate the overall effects. RESULTS: A total of 19 trials (1193 participants) were included. The analysis showed that diet was significantly related to improvements in IR and body composition (eg, homeostasis model assessment of insulin resistance, fasting insulin, fasting plasma glucose, body mass index [BMI], weight, and waist circumference) in PCOS patients. The Dietary Approaches to Stop Hypertension diet and calorie-restricted diets might be the optimal choices for reducing IR and improving body composition, respectively, in the PCOS population. Additionally, the effects were associated with the course of treatment. The longer the duration, the greater the improvement was. Compared with metformin, diet was also advantageous for weight loss (including BMI and weight) and had the same effects on insulin regulation. CONCLUSION: Overall, our findings suggest that diet is an effective, acceptable and safe intervention for relieving IR, and professional dietary advice should be offered to all PCOS patients.
Overview
CoChat Summary
TL;DR
In this systematic review and meta-analysis of 19 RCTs (1193 women with PCOS), dietary interventions significantly improved insulin resistance and body composition compared with minimal intervention. Diet was comparable to metformin for insulin outcomes and superior for weight/BMI loss, with DASH and calorie-restricted diets appearing optimal for IR and weight management, respectively.
Key findings
- Diet versus minimal intervention significantly reduced HOMA-IR (MD = –0.78, 95% CI –0.92 to –0.65; P < .00001; I² = 24%), fasting insulin (MD = –4.24 mIU/L, 95% CI –5.37 to –3.10; P < .00001; I² = 80%), fasting plasma glucose (MD = –0.11 mmol/L, 95% CI –0.17 to –0.04; P = .002; I² = 0%), BMI (MD = –1.01 kg/m², 95% CI –1.38 to –0.64; P < .00001; I² = 54%), weight (MD = –1.74 kg, 95% CI –2.42 to –1.05; P < .00001; I² = 59%), and waist circumference (MD = –3.25 cm, 95% CI –5.29 to 1.22 cm; P = .002; I² = 41%); waist–hip ratio did not change significantly (MD = –0.01, 95% CI –0.02 to 0.00; P = .20; I² = 0%).
- Subgroup analyses suggested the DASH diet was more beneficial for HOMA-IR than a low-carbohydrate diet, and calorie-restricted diets were more beneficial for BMI and weight; longer treatment duration was associated with greater improvement, except for fasting plasma glucose.
- Diet versus metformin showed no differences in HOMA-IR (MD = –0.09, 95% CI –0.46 to 0.28; P = .63; I² = 38%), fasting insulin (MD = –0.15 mIU/L, 95% CI –1.34 to 1.04; P = .81; I² = 45%), or fasting plasma glucose (MD = 0.01 mmol/L, 95% CI –0.13 to 0.15; P = .85; I² = 53%).
- Compared with metformin, diet produced greater reductions in BMI (MD = –2.49 kg/m², 95% CI –2.73 to –2.25; P < .00001; I² = 0%), weight (MD = –5.46 kg, 95% CI –5.79 to –5.13; P < .00001; I² = 0%), and waist circumference (MD = –3.63 cm, 95% CI –7.18 to –0.08; P = .05; I² = 0%); the paper reports no additional benefit for waist–hip ratio (MD = –0.06, 95% CI –0.10 to –0.02; P = .003; I² = 86%).
Methods
- Systematic review and meta-analysis following PRISMA guidelines, registered in PROSPERO (CRD42019140454); 8 databases were searched through June 30, 2019.
- Included 19 RCTs with 1193 women diagnosed with PCOS: 15 trials compared diet with minimal intervention (853 participants) and 4 compared diet with metformin (340 participants); dietary patterns included low-carbohydrate, DASH, calorie-restricted, low-fat, and Mediterranean diets, with intervention durations from 4 weeks to 1 year.
- Random-effects models were used to calculate pooled mean differences or standardized mean differences with 95% CIs; heterogeneity was assessed with Cochran’s Q and I², with subgroup analyses by dietary pattern and treatment duration (≤12 weeks or >12 weeks), sensitivity analysis excluding high-risk-of-bias trials, and Egger’s test/funnel plots when more than 10 trials were available.
Limitations
- Stated by the authors: evidence involved few countries and ethnic groups; limited numbers of trials and small sample sizes for some outcomes; heterogeneity was present in some results due to differing dietary patterns, metformin dosages, and population characteristics; no included trials targeted a specific PCOS phenotype; most trials lasted ≤12 weeks; and the impact of diet independent of weight loss remains unclear.
- Evident from the text: only 1 trial explained allocation concealment, 4 trials were judged high risk due to >20% attrition, and publication-bias tests were low-powered because fewer than 10 studies were available for most outcomes.
- Stated by the authors: meta-regression was limited by the paucity of available studies, and the results for waist circumference and waist–hip ratio in the diet-versus-metformin comparison should be interpreted with caution.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 0 Not valid · 12 Not checked · 27 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although the causes of PCOS have not yet been fully defined, insulin resistance (IR) has been indicated as a key etiological component (6).”
What the sources say
- Supportedcites [6] Dumesic, 2015, Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome, Endocr Rev. source
The Introduction identifies insulin resistance and hyperinsulinemia as prominent factors in the complex pathophysiology of PCOS. The Insulin sensitivity and secretion section also calls them hallmarks of PCOS, supporting the hedged description of insulin resistance as a key component without claiming it is the sole cause. (LLM, conf=0.88)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, the efficacy of metformin in terms of improving clinical outcomes remains uncertain (12).”
What the sources say
- Supportedcites [12] Sam, 2017, Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome, Diabetologia. source
In “Impact of metformin on the clinical features of PCOS,” the paper says whether metformin benefits women with PCOS remains unclear and that reliable clinical data are insufficient to support its broad use. The Conclusions likewise describe heterogeneous responses and a lack of clear benefit. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“and 4 trials were judged as high risk due to the high attrition rate (more than 20%) across intervention groups (31-33, 47).”
What the sources say
- Not checked — no full text of the sourcecites [31] Moran, 2003, Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome, J Clin Endocrinol Metab. source
- Not checked — no full text of the sourcecites [32] Stamets, 2004, A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome, Fertil Steril. source
- Supportedcites [33] Moran, 2010, The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome, Fertil Steril. source
The paper reports 22 women randomized to the low-protein group and 24 to the high-protein group, with 14 completing in each group (Abstract and Table 1; page unavailable). Attrition therefore exceeded 20% in both groups. The 'high risk' judgment and the count of four trials are the citing authors' assessment, not findings attributed to this individual trial. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [47] Esfahanian, 2013, Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome, J Obstet Gynaecol Res. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Updated meta-analyses and clinical trials also suggested that the greater energy restriction is, the greater the weight loss will be, regardless of where the restriction comes from (carbohydrates, protein, or fat) (63, 64).”
What the sources say
- Partly supportedcites [63] Naude, 2014, Low carbohydrate versus isoenergetic balanced diets for reducing weight and cardiovascular risk: a systematic review and meta-analysis, PLoS One. sourceExperimental — accuracy not yet measured
The Discussion (Overall completeness and applicability of evidence; page unavailable) attributes weight loss to reduced total energy intake rather than macronutrient composition. But the review compared diets with similar energy prescriptions; it does not establish that progressively greater energy restriction produces progressively greater weight loss. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [64] Nordmann, 2006, Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials, Arch Intern Med. source
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“Four trials (299 participants) mentioned FPG in comparison with diet and metformin (46-49). The results of the meta-analysis showed no significant difference (MD = 0.01 mmol/L, 95% CI –0.13 to 0.15 mmol/L; P = .85; I2 = 53%) (Fig. 4).”
What the sources say
- Not checked — no full text of the sourcecites [46] Qublan, 2007, Dietary intervention versus metformin to improve the reproductive outcome in women with polycystic ovary syndrome. A prospective comparative study, Saudi Med J. source
- Not checked — no full text of the sourcecites [47] Esfahanian, 2013, Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome, J Obstet Gynaecol Res. source
- Not matchedcites [48] Li, 2017, Clinical observation of personalized diet intervention and metformin in the treatment of polycystic ovary syndrome, Matern Child Heal Care China.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [49] Ge, 2017, Effect of individualized diet intervention on insulin resistance and pregnancy in infertile patients with PCOS, ACTA Acad Med QINGDAO Univ.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainn = 299- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
14 more claims
Create a free account to see all 47 claims and every source verdict.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 18
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This process has the potential to be reversible following changes in diet quantity and quality, as has been shown to occur with calorie restriction, fasting, time-restricted eating, gastric bypass surgery, low saturated fat and low glycemic diets [168,170,173].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [170]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous studies have shown that dietary modification [168,169,170], or treatment with probiotics or synbiotics, has the potential to restore normal insulin function [57,171].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [170]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another meta-analysis of 19 trials comprising 1193 participants confirmed that the DASH diet was superior to other eating patterns in improving insulin resistance in women with PCOS [45].”
From Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome (2024) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In women with PCOS, studies suggest that an appropriate diet, such as the DASH diet and other calorie-restricted diets, has a beneficial effect on handling insulin resistance (IR) and body weight management [23].”
From Dietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS (2025) · cites this paper as [23]
In the citing paper
“The authors observed that dietary changes were significantly related to decreased IR and improved body composition in women with PCOS and identified that the DASH diet and calorie-restricted diets were most effective in improving insulin sensitivity in PCOS [16].”
From Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS) (2023) · cites this paper as [16]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“WC. In total, 5 studies (227 participants) mentioned the changes in WC (32, 35, 39, 41, 45). Adherence to the diet treatment was found to have a significant overall ef- fect on WC (MD = –3.25 cm, 95% CI –5.29 to 1.22 cm; P = .002; I2 = 41%)”
Reported -3.25 · recomputed -2.035
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results
“After removing 148 duplicated studies, 304 records were assessed by screening titles and abstracts.”
§ Results
“Records a�er duplicates removed (n = 148)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“>12 weeks 2 55 –0.15 (–0.71, –0.40) 57% .59”
Reported -0.15 · recomputed -0.555
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ 3. random* [tw]
“Studies that met the following inclu- sion criteria were included: (1) parallel controlled RCTs”
§ Results
“Except for the trial conducted by Gower et al. (crossover study) (36), all of them were parallel-design”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Results
“benefits of adjusting WHR (MD = –0.06, 95% CI –0.10 to –0.02; P = .003; I2 = 86%) compared with metformin”
§ 3. random* [tw]
“P < .05 represented statistical significance.”
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Correlates of adults??? participation in physical activity: review and update
TROST, S. G., OWEN, N., BAUMAN, A. E., SALLIS, J. F., & BROWN, W. (2002) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200212000-00020 · Cited by 3,040
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Research works printed but not linked: 7
- 2014, Review Manager (RevMan) [Computer program]. Version 5.3
- Cheng, 2016, Effect of diet intervention on quality of life and fasting insulin levels in patients with polycystic ovary syndrome, Tianjin J Nurs., 24, 249
- Xu, 2017, Effects of Mediterranean diet on reproductive function in patients with obese polycystic ovary syndrome, Matern Child Heal Care China., 32, 122
- Li, 2017, The effect of dietary guidance on polycystic ovary syndrome, J Med Theory Pract., 30, 3745
- Li, 2017, Clinical observation of personalized diet intervention and metformin in the treatment of polycystic ovary syndrome, Matern Child Heal Care China., 32, 2535
- Ge, 2017, Effect of individualized diet intervention on insulin resistance and pregnancy in infertile patients with PCOS, ACTA Acad Med QINGDAO Univ., 53, 523
- Josiemer, 2017, The Mediterranean diet score is more strongly associated with favorable cardiometabolic risk factors over 2 years than other diet quality indexes in Puerto Rican adults, J Nutr., 147
Cited by
Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041454 · Cited by 521
“A meta-analysis and systematic review concluded that an LGI diet is an effective, acceptable, and safe intervention for IR relief, and that professional dietary counselling should be provided to all PCOS patients [49,50].”
BackgroundPolycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445
“Insulin stimulates adipogenesis and lipogenesis and inhibits lipolysis [42], resulting in fat accumulation [44].”
BackgroundInsulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 385
Lifestyle management in polycystic ovary syndrome – beyond diet and physical activity
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., Blackmore, R., Naderpoor, N., Bennett, C., Ee, C., et al. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01208-y · Cited by 240
“DASH 1 SR/MA (19 RCT total ‐ 4 RCT using DASH diet) [85] 4; 228 Dietary intervention ↓ HOMA‐IR, FINS, FGL, BMI, BW, WC compared with minimal intervention, and subgroup analysis showed DASH diet was more effective at improving insulin sensitivity [85] Shang et al.”
BackgroundMethodInfluentialMetabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites
Chen, W., & Pang, Y. (2021) · Metabolites · doi:10.3390/metabo11120869 · Cited by 228
Metadata
- Authors
- Shang, Y., Zhou, H., Hu, M., & Feng, H.
- Affiliations
- Nanjing University of Chinese Medicine (CN)
- Corresponding author
- Zhou, Huifang
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2020-07-04
- Volume
- 105
- Issue
- 10
- Pages
- 3346-3360
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W3038172358
- Cited by
- 171
- References
- 71
- Citations by year
- 2026: 21 · 2025: 29 · 2024: 31 · 2023: 36 · 2022: 31 · 2021: 19 · 2020: 4
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81774354, 81973898)
- Jiangsu Administration of Traditional Chinese Medicine Bureau (ZD201702)
- Jiangsu Leading Talents Project of Traditional Chinese Medicine (SLJ0202)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- polycystic ovary syndrome, insulin resistance, dietary intervention, DASH diet, calorie-restricted diet, body composition, weight loss, metformin, fasting insulin, waist circumference, body mass index
- MeSH terms
- Dietary Approaches To Stop Hypertension, Blood Glucose, Counseling, Dietary Services, Fasting, Female, Humans, Insulin, Insulin Resistance, Polycystic Ovary Syndrome, Time Factors, Weight Loss, Body Mass Index, Treatment Outcome, Caloric Restriction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome. https://app.cochat.ai/papers/10.1210/clinem/dgaa425
- The paper
- Shang, Y., Zhou, H., Hu, M., & Feng, H. (2020). Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaa425
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.